Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target-derived from an antibody identified using its discovery platform.
-20%
If you want not to miss ideas like this one,๐ฏ subscribe and press a thumb up! ๐ Have a question? Don't be shy to ask! ๐ค Interested to study how to analyze charts, follow me!